Primary Site >> Liver Cancer
Gene >> AXL
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
Ref: Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma. PMID: 9676427 |
Ref: Differential expression of Axl in hepatocellular carcinoma and correlation with tumor lymphatic metastasis. PMID: 20635370 |
Ref: AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. PMID: 21076472 |
Ref: Genes responsible for the characteristics of primary cultured invasive phenotype hepatocellular carcinoma cells. PMID: 22681909 Ref: Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma. PMID: 23082053 |
Ref: Receptor tyrosine kinases: principles and functions in glioma invasion. PMID: 22879068 Ref: Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. PMID: 24113455 |
Ref: Gas6/Axl pathway promotes tumor invasion through the transcriptional activation of Slug in hepatocellular carcinoma. PMID: 24233839 Ref: Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway. PMID: 24347489 Ref: The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. PMID: 24837142 |
Ref: Axl activates autocrine transforming growth factor-beta signaling in hepatocellular carcinoma. PMID: 25251599 Ref: When good transforming growth factor-beta turns bad in hepatocellular carcinoma: Axl takes the stage. PMID: 25429775 Ref: Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma. PMID: 25529751 Ref: Antitumor effect of metformin on cholangiocarcinoma: In vitro and in vivo studies. PMID: 26398221 Ref: MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells. PMID: 26722228 |
Ref: Overexpression of Tyro3 and its implications on hepatocellular carcinoma progression. PMID: 26573872 Ref: Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma. PMID: 27182739 |
Ref: A Phase I/II Multicenter Study of Single-Agent Foretinib as First-Line Therapy in Patients with Advanced Hepatocellular Carcinoma. PMID: 27821605 Ref: Integrated analysis of gene expression and copy number identified potential cancer driver genes with amplification-dependent overexpression in 1,454 solid tumors. PMID: 28377632 Ref: Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study. PMID: 28426123 Ref: RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma. PMID: 28460436 Ref: Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis. PMID: 28526812 Ref: Cabozantinib in the treatment of hepatocellular carcinoma. PMID: 28703624 Ref: Phase II randomised discontinuation trial of cabozantinib in patients with advanced solid tumours. PMID: 29059635 Ref: The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis. PMID: 29072690 |
Ref: Dynamics of CRISPR/Cas9-mediated genomic editing of the AXL locus in hepatocellular carcinoma cells. PMID: 29434956 Ref: Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma. PMID: 29972759 Ref: Transforming Growth Factor-beta and Axl Induce CXCL5 and Neutrophil Recruitment in Hepatocellular Carcinoma. PMID: 30014484 |